Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Completed · Phase 2

Conditions studied: Nonalcoholic Steatohepatitis

In brief

The primary objective of this study is to evaluate the safety and tolerability of study drug(s) in participants with nonalcoholic steatohepatitis (NASH).

Key facts

Study ID
NCT03987074
Run by
Gilead Sciences
People needed
109
Starts
2019-07-29
Expected to finish
2020-07-13
Last updated by the study team
2021-07-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.